Related Experiment Video
Updated: Oct 4, 2025

Analysis of Retinoic Acid-induced Neural Differentiation of Mouse Embryonic Stem Cells in Two and Three-dimensional Embryoid Bodies
Published on: April 22, 2017
The Different Impact of ERK Inhibition on Neuroblastoma, Astrocytoma, and Rhabdomyosarcoma Cell Differentiation
T D Lebedev1, E R Vagapova1, V S Prassolov1
1Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, 119991 Russia.
Abstract:
Aberrant ERK activity can lead to uncontrolled cell proliferation, immortalization, and impaired cell differentiation. Impairment of normal cell differentiation is one of the critical stages in malignant cell transformation. In this study, we investigated a relationship between ERK tyrosine kinase activity and the main differentiation features (changes in cell morphology and expression of genes encoding differentiation markers and growth factor receptors) in SH-SY5Y neuroblastoma, U-251 astrocytoma, and TE-671 rhabdomyosarcoma cells. ERK activity was assessed using a reporter system that enabled live measurements of ERK activity in single cells. We demonstrated that suppression of ERK activity by selective ERK inhibitors, in contrast to a commonly used differentiation inducer, retinoic acid, leads to significant changes in TE-671 cell morphology and expression of the myogenic differentiation marker genes PROM1, MYOG, and PAX7. There was a relationship between ERK activity and morphological changes at an individual cell level. In this case, SH-SY5Y cell differentiation induced by retinoic acid was ERK-independent. We showed that ERK inhibition increases the sensitivity of TE-671 cells to the EGF, IGF-1, and NGF growth factors, presumably by reducing basal ERK activity, and to the BDNF growth factor, by increasing expression of the TrkB receptor.
Insights
Aberrant ERK activity impairs cell differentiation. Suppressing ERK in TE-671 rhabdomyosarcoma cells altered morphology and myogenic gene expression, suggesting ERK
Area of Science:
- Cell Biology
- Molecular Biology
- Cancer Research
Background:
- Aberrant ERK (extracellular signal-regulated kinase) activity is linked to uncontrolled cell proliferation and malignant transformation.
- Impaired cell differentiation is a hallmark of cancer development.
- Understanding the role of ERK in differentiation is crucial for developing targeted cancer therapies.
Purpose of the Study:
- To investigate the relationship between ERK tyrosine kinase activity and differentiation features in neuroblastoma, astrocytoma, and rhabdomyosarcoma cell lines.
- To determine if ERK inhibition or induction affects cell morphology and gene expression related to differentiation.
- To explore the impact of ERK modulation on growth factor sensitivity in cancer cells.
Main Methods:
- Utilized a reporter system for real-time, single-cell measurement of ERK activity.
- Employed selective ERK inhibitors to suppress ERK activity.
- Analyzed changes in cell morphology and the expression of specific differentiation marker genes (PROM1, MYOG, PAX7).
- Assessed the impact of ERK inhibition on cellular responses to growth factors (EGF, IGF-1, NGF, BDNF).
Main Results:
- Suppression of ERK activity significantly altered TE-671 rhabdomyosarcoma cell morphology and expression of myogenic differentiation markers.
- A direct correlation was observed between ERK activity levels and morphological changes at the single-cell level.
- SH-SY5Y neuroblastoma cell differentiation induced by retinoic acid was found to be independent of ERK activity.
- ERK inhibition enhanced TE-671 cell sensitivity to EGF, IGF-1, and NGF, and to BDNF via increased TrkB receptor expression.
Conclusions:
- ERK activity plays a significant role in regulating differentiation in specific cancer cell types, such as rhabdomyosarcoma.
- ERK inhibition can induce differentiation-like changes and modulate growth factor responses in certain cancer cells.
- ERK-independent pathways are involved in the differentiation of other cancer cell types, like neuroblastoma.
Related Concept Videos
Mitogens and the Cell Cycle
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Inhibition of Cdk Activity

